Published in J Vasc Res on January 13, 2012
Vein graft adaptation and fistula maturation in the arterial environment. J Surg Res (2014) 0.90
Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes. Am J Kidney Dis (2016) 0.82
How is arteriovenous fistula longevity best prolonged?: The role of surveillance. Semin Dial (2014) 0.77
c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae. Am J Physiol Renal Physiol (2014) 0.76
Future research directions to improve fistula maturation and reduce access failure. Semin Vasc Surg (2016) 0.76
Effects of Tongmai oral liquid in femoral ateriovenous fistula. BMC Complement Altern Med (2015) 0.75
Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model. Sci Rep (2016) 0.75
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis (2007) 2.34
Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol (2007) 2.27
Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis (2000) 2.05
Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol (2007) 1.88
Biology of arteriovenous fistula failure. J Nephrol (2007) 1.66
Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int (2006) 1.51
Arteriovenous fistula in the rat tail: a new model of hemodialysis access dysfunction. Kidney Int (2008) 1.48
CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol (2009) 1.40
Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol (2005) 1.32
Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant (2009) 1.29
Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb (1993) 1.27
Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res (1990) 1.24
Venous stenosis in a pig arteriovenous fistula model--anatomy, mechanisms and cellular phenotypes. Nephrol Dial Transplant (2007) 1.22
Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis (2000) 1.18
Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol (2001) 1.18
Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol (2010) 1.15
Chronic kidney disease aggravates arteriovenous fistula damage in rats. Kidney Int (2010) 1.10
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol (2009) 1.05
Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res (1991) 1.05
Chronic arteriovenous shunt: evaluation of a model for heart failure in rat. Am J Physiol (1979) 1.01
Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats. J Vasc Surg (2007) 0.99
Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats--influence of sex, strain, and surgical procedure. Exp Toxicol Pathol (2005) 0.97
Early and sustained medial cell activation after aortocaval fistula creation in mice. J Surg Res (2002) 0.94
Degradation of the internal elastic laminae in vein grafts of rats with aortocaval fistulae: potential impact on graft vasculopathy. Am J Pathol (2009) 0.87
Stress-induced senescence exaggerates postinjury neointimal formation in the old vasculature. Am J Physiol Heart Circ Physiol (2009) 0.86
Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project. Am J Kidney Dis (1999) 0.83
Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure. Nephrol Dial Transplant (2005) 0.80
Early and late fistula failure. Clin Nephrol (2008) 0.79
Vascular pathology of balloon-expandable flexible coil stents in humans. J Am Coll Cardiol (1992) 0.78
Aging and transplant arteriosclerosis in absence of alloreactivity and immunosuppressive drugs in a rat aortic model: recipient age's contribution. Transplantation (2005) 0.77
Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest (2007) 3.63
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51
Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest (2005) 2.38
Is there still a glass ceiling for women in academic surgery? Ann Surg (2011) 2.33
Idiopathic mid-aortic syndrome in children. Pediatr Nephrol (2008) 2.14
Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques. J Vasc Surg (2002) 2.05
New tunneled hemodialysis catheter placement through the old exit site. Semin Dial (2008) 2.04
Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem (2009) 1.81
Biology of arteriovenous fistula failure. J Nephrol (2007) 1.66
Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal (2008) 1.66
The origin of post-injury neointimal cells in the rat balloon injury model. Cardiovasc Res (2008) 1.61
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61
Notch signaling: emerging molecular targets for cancer therapy. Biochem Pharmacol (2010) 1.54
Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol (2005) 1.51
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal (2011) 1.51
Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovascular Surg (2005) 1.50
Antibiotic prophylaxis: is it needed for dialysis access procedures? Semin Dial (2009) 1.40
Arteriovenous fistula creation: should US nephrologists get involved? Am J Kidney Dis (2003) 1.39
Retrograde angiography and the risk of arteriovenous fistula perforation. Semin Dial (2009) 1.39
Renal failure and cardiac rhythm device infection. J Cardiovasc Electrophysiol (2011) 1.38
Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res (2009) 1.36
Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks. FASEB J (2002) 1.31
Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol (1985) (2008) 1.30
CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol (2006) 1.27
Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells (2006) 1.27
Femoral neuropathy following retroperitoneal hemorrhage: case series and review of the literature. Ann Vasc Surg (2006) 1.19
Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J (2006) 1.17
Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis (2012) 1.16
Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development. Vasc Endovascular Surg (2006) 1.16
Arteriovenous access and hand pain: the distal hypoperfusion ischemic syndrome. Clin J Am Soc Nephrol (2006) 1.11
Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg (2005) 1.09
Complex vascular reconstruction of abdominal aorta and its branches in the pediatric population. J Pediatr Surg (2008) 1.07
A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res (2008) 1.05
Outcomes of accessory renal artery occlusion during endovascular aneurysm repair. J Vasc Surg (2006) 1.04
Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. J Vasc Surg (2002) 1.04
Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. J Vasc Surg (2008) 1.03
Role of surgical intervention for cephalic arch stenosis in the "fistula first" era. Semin Dial (2007) 1.02
Clinical epidemiology of arteriovenous fistula in 2007. J Nephrol (2007) 1.02
A novel technique for tethered dialysis catheter removal using the laser sheath. Semin Dial (2009) 1.01
Pre-uremic calciphylaxis. Iran J Kidney Dis (2014) 1.01
Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself? Semin Dial (2011) 0.99
The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg (2006) 0.99
Impact of surgeon selection on access placement and survival following preoperative mapping in the "Fistula First" era. Semin Dial (2008) 0.98
Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. Mol Cell Biol (2008) 0.98
Risk factors for restenosis after carotid artery angioplasty and stenting. J Vasc Surg (2006) 0.98
Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients. J Microbiol Immunol Infect (2012) 0.97
Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol (2010) 0.95
Cephalic arch stenosis: mechanisms and management strategies. Semin Nephrol (2012) 0.94
Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Curr Atheroscler Rep (2012) 0.93
Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther (2010) 0.93
VEGF-A and alphaVbeta3 integrin synergistically rescue angiogenesis via N-Ras and PI3-K signaling in human microvascular endothelial cells. FASEB J (2003) 0.92
Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol (2012) 0.92
Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg (2010) 0.92
A comparison of renal function between open and endovascular aneurysm repair in patients with baseline chronic renal insufficiency. J Vasc Surg (2006) 0.91
Use of CT angiography to classify endoleaks after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol (2005) 0.90
Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular (2006) 0.90
Cephalic arch stenosis. Semin Dial (2007) 0.89
Surgical salvage of the autogenous arteriovenous fistula (AVF). J Nephrol (2007) 0.89
Focused vascular access education to reduce the use of chronic tunneled hemodialysis catheters: results of a network quality improvement initiative. Semin Dial (2009) 0.89
Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies. Semin Dial (2006) 0.89
Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells. J Immunol (2013) 0.88
Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing. Ann Surg (2010) 0.88
Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective study. J Am Coll Surg (2009) 0.88
Autogenous arteriovenous fistula options. J Nephrol (2007) 0.88
Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Ann Surg (2011) 0.87
Physical examination of arteriovenous fistulae by a renal fellow: does it compare favorably to an experienced interventionalist? Semin Dial (2008) 0.87
Techniques for preserving vertebral artery perfusion during thoracic aortic stent grafting requiring aortic arch landing. Vasc Endovascular Surg (2006) 0.87
Stent placement in hemodialysis access: historical lessons, the state of the art and future directions. Clin J Am Soc Nephrol (2009) 0.87
Stress-induced senescence exaggerates postinjury neointimal formation in the old vasculature. Am J Physiol Heart Circ Physiol (2009) 0.86
Surgical management of cephalic arch occlusive lesions: are there predictors for outcomes? Semin Dial (2013) 0.86
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. J Transplant (2012) 0.86
Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. PLoS One (2012) 0.86
Limb interventions in patients undergoing treatment with an unsupported bifurcated aortic endograft system: a review of the Phase II EVT Trial. J Vasc Surg (2002) 0.85
Stent graft for nephrologists: concerns and consensus. Clin J Am Soc Nephrol (2010) 0.85
A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg (2012) 0.85
Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling. Am J Physiol Heart Circ Physiol (2014) 0.85
Mineral volume and morphology in carotid plaque specimens using high-resolution MRI and CT. Arterioscler Thromb Vasc Biol (2005) 0.84
Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. J Vasc Surg (2002) 0.83
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta (2013) 0.83
Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of Wnt11-dependent WISP-1. PLoS One (2012) 0.83
Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity. Am J Kidney Dis (2003) 0.83
Accuracy of physical examination in the detection of arteriovenous graft stenosis. Semin Dial (2008) 0.82
Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice. Wound Repair Regen (2015) 0.82
Long-term outcomes of community-acquired versus hospital-acquired acute kidney injury: a retrospective analysis. Clin Nephrol (2014) 0.81
Nicotinic and PDGF-receptor function are essential for nicotine-stimulated mitogenesis in human vascular smooth muscle cells. J Cell Biochem (2005) 0.81
Dynamic regulation of vascular myosin light chain (MYL9) with injury and aging. PLoS One (2011) 0.81
A novel mouse model of in-stent restenosis. Atherosclerosis (2009) 0.81
Normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen. Surgery (2005) 0.81